middle.news
Recce Pharmaceuticals Advances Phase 3 Trials and Nears Licensing Deal in MENA
12:20pm on Tuesday 21st of July, 2026 AEST
•
Healthcare
Read Story
Recce Pharmaceuticals Advances Phase 3 Trials and Nears Licensing Deal in MENA
12:20pm on Tuesday 21st of July, 2026 AEST
Key Points
Non-binding licensing term sheet with leading Middle Eastern pharma
HREC approval upgrades Australian trial to pivotal Phase 3
Successful Indonesian regulatory inspection with no findings
A$4 million raised via institutional placement, SPP underway
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Recce Pharmaceuticals (ASX:RCE)
OPEN ARTICLE